bevacizumabNelmastobarttrifluridine/tipiracilmCRCMetastatic colorectal cancer (mCRC)
… 52.1%.Conclusions Nelmastobart plus trifluridine/tipiracil and bevacizumab was well tolerated, with no drug-related toxicities. BTN1A1 exp…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… 52.1%.Conclusions Nelmastobart plus trifluridine/tipiracil and bevacizumab was well tolerated, with no drug-related toxicities. BTN1A1 exp…
…mastobart, and no treatment-related deaths occurred.Conclusions Nelmastobart combined with capecitabine demonstrated a manageable safety pro…